Notably, adiponectin levels inversely correlate with body mass index (BMI) and visceral adiposity, linking it to obesity-related conditions such as metabolic syndrome, type 2 diabetes, insulin resistance, and cardiovascular diseases, including hypertension [4–10]. Here, ADIPOQ is linked to metabolic syndrome.